Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Response on the IFW for the '148 app 90/008,227 now. eom

As anticipated, Henneman has again successfully debunked the combinations of prior art used to raise any SNQs in the ex parte requests.

It is always a pleasure to read his countervailing refutations and I shall miss these once all validity challenges are ended. A small price to pay, I suppose, for watertight "patents on water".

.

.

Be well

Share
New Message
Please login to post a reply